Smoking's effect on lower-limb speed and coordination in young adults.
Investigation of the Impact of Smoking Addiction on the Speed and Coordination of Lower Extremity Movements
Saglik Bilimleri Universitesi · NCT07061522
We will test whether young adults who smoke have slower or less coordinated leg movements compared with non-smokers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 24 (estimated) |
| Ages | 18 Years to 25 Years |
| Sex | All |
| Sponsor | Saglik Bilimleri Universitesi (other) |
| Locations | 1 site (Istanbul, Üsküdar) |
| Trial ID | NCT07061522 on ClinicalTrials.gov |
What this trial studies
This observational case-control study compares motor coordination and sprint speed between smokers and non-smokers aged 18–25. Participants are classified using DSM-IV-TR nicotine dependence criteria and the Fagerström Test and will complete the Lower Extremity Motor Coordination Test (LEMOCOT) and a 30-meter sprint under standardized laboratory conditions. BMI and bimalleolar diameter and circumference will be recorded to control for body-size confounders. Data will be analyzed to see if chronic smoking is associated with measurable deficits in lower-limb motor function.
Who should consider this trial
Good fit: Ideal participants are literate, cooperative adults aged 18–25 with BMI 18.5–29.9 who either smoke at least one cigarette daily for 12 months or more or are non-smokers for comparison.
Not a fit: People with orthopedic, neurological, or neuromuscular conditions, chronic pulmonary or cardiac disease, cognitive impairment, or BMI ≥30 are excluded and unlikely to benefit from this protocol.
Why it matters
Potential benefit: If smoking is linked to poorer lower-limb function, the findings could support early prevention and targeted rehabilitation to help preserve mobility in young smokers.
How similar studies have performed: Previous research links smoking to vascular and neuromuscular harm, but few controlled studies have directly measured lower-limb coordination and sprint performance, making this approach relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Smoking ≥1 cigarette daily for at least 12 months * Age between 18-25 * Literate and cooperative * BMI: 18.5-29.9 kg/m² Exclusion Criteria: * Orthopedic, neurological, or neuromuscular conditions impairing walking * Chronic pulmonary or cardiac disease * Cognitive impairment * BMI ≥30 kg/m²
Where this trial is running
Istanbul, Üsküdar
- Esra Pehlivan — Istanbul, Üsküdar, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Esra Pehlivan, Associate Professor
- Email: esra.pehlivan@sbu.edu.tr
- Phone: +90216 777 87 77
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Smoking Cessation